Table 3.
Cost per person per procedure by specific resource or economic categories, by country or by breast cancer stage
| By country or stage |
Diagnosis costs | Drug costs | Other medical costs | Indirect costs | Across all categories | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C/Sa | Median | Range | C/Sa | Median | Range | C/Sa | Median | Range | C/Sa | Median | Range | C/Sa | Median | Range | |
| US | – | – | – | – | – | – | 10/5 | $7,096 | (707, 30,730) | 2/1 | $278 | (276, 280) | 12/6 | $3,809 | (276, 30,730) |
| Canada | – | – | – | – | – | – | 2/1 | $616 | (224, 1009) | – | – | – | 2/1 | $616 | (224, 1009) |
| Australia | 1/1 | $320 | (320, 320) | – | – | – | 1/1 | $258 | (258, 258) | – | – | – | 2/2 | $289 | (258, 320) |
| UK | – | – | – | – | – | – | 6/2 | $3,187 | (1347, 8916) | – | – | – | 6/2 | $3,187 | (1347, 8916) |
| Italy | – | – | – | – | – | – | 8/3 | $3,607 | (1989, 4500) | – | – | – | 8/3 | $3,607 | (1989, 4500) |
| Netherlands | – | – | – | 2/1 | $2,149 | (2149, 2149) | 2/1 | $2,466 | (2400, 2533) | 2/1 | $24 | (13, 34) | 6/1 | $2,149 | (13, 2533) |
| Europe total | – | – | – | 2/1 | $2,149 | (2149, 2149) | 16/6 | $3,592 | (1347, 8916) | 2/1 | $24 | (13, 34) | 20/6 | $2,619 | (13, 8916) |
| Early only | – | – | – | – | – | – | 12/5 | $3,607 | (224, 30,730) | 2/1 | $278 | (276, 280) | 14/6 | $3,592 | (224, 30,730) |
| Metastatic only | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Both | – | – | – | 2/1 | $2,149 | (2149, 2149) | 3/2 | $2,400 | (1322, 2533) | 2/1 | $24 | (13, 34) | 7/2 | $2,149 | (13, 2533) |
| Not reported | 1/1 | $320 | (320, 320) | – | – | – | 14/6 | $3,187 | (707, 20,772) | – | – | – | 15/7 | $2,704 | (320, 20,772) |
| Total | 1/1 | $320 | (320, 320) | 2/1 | $2,149 | (2149, 2149) | 29/13 | $3,586 | (224, 30,730) | 4/2 | $155 | (13, 280) | 36/15 | $2,466 | (13, 30,730) |
The country inclusion criteria were the US, Canada, Australia and Western Europe (UK, France, Germany, Spain, Italy, Norway, Sweden, Denmark, Netherlands and Switzerland). If a country does not appear in the table, it is because a relevant article and/or cost for this table was not identified. All costs are standardised to US$2022
aC/S costs/studies: the median and range is constructed across a range of individual procedure cost estimates both within and across studies which were not combined. As such, the C/S statistic suggests how many costs and studies the median and range was constructed from. For example, 1/1 means one cost from one study was included (in these cases, the range is the same as the median). Alternatively, 16/6 means 16 cost estimates are accounted across 6 studies, with the median being from the 16 cost estimates, and the range indicating the lower and highest cost estimates